These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 7386473)
1. Recommended standards of practice, policies, and procedures for intravenous therapy. National Coordinating Committee on Large Volume Parenterals. Am J Hosp Pharm; 1980 May; 37(5):660-3. PubMed ID: 7386473 [TBL] [Abstract][Full Text] [Related]
2. Recommended guidelines for quality assurance in hospital centralized intravenous admixture services. National Coordinating Committee on Large Volume Parenterals. Am J Hosp Pharm; 1980 May; 37(5):645-55. PubMed ID: 7386471 [TBL] [Abstract][Full Text] [Related]
3. Recommendations to pharmacists for solving problems with large-volume parenterals-1979. National Coordinating Committee on Large Volume Parenterals. Am J Hosp Pharm; 1980 May; 37(5):663-7. PubMed ID: 7386474 [No Abstract] [Full Text] [Related]
4. Recommendations for the labeling of large volume parenterals. National Coordinating Committee on Large Volume Parenterals. Am J Hosp Pharm; 1978 Jan; 35(1):49-51. PubMed ID: 623118 [TBL] [Abstract][Full Text] [Related]
5. Pharmacists' opinions about and compliance with recommendations for intravenous admixture practices. Brzozowski DF; Hale KM; Segal R; Mirtallo JM Am J Hosp Pharm; 1987 Sep; 44(9):2077-84. PubMed ID: 3479020 [TBL] [Abstract][Full Text] [Related]
6. Recommended procedures for in-use testing of large volume parenterals suspected of contamination or of producing a reaction in a patient. National Coordinating Committee on Large Volume Parenterals. Am J Hosp Pharm; 1978 Jun; 35(6):678-82. PubMed ID: 665681 [TBL] [Abstract][Full Text] [Related]
7. Recommended methods for compounding intravenous admixtures in hospitals. Am J Hosp Pharm; 1975 Mar; 32(3):261-70. PubMed ID: 1136973 [TBL] [Abstract][Full Text] [Related]
11. The NCI All Ireland Cancer Conference. Johnston PG; Daly PA; Liu E Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862 [TBL] [Abstract][Full Text] [Related]
12. Six Sigma: not for the faint of heart. Benedetto AR Radiol Manage; 2003; 25(2):40-53. PubMed ID: 12800564 [TBL] [Abstract][Full Text] [Related]
13. Guidelines for phenytoin infusions. Tuttle CB Can J Hosp Pharm; 1984; 37(4):137-9. PubMed ID: 10269318 [TBL] [Abstract][Full Text] [Related]
15. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings. Sneed RC; May WL; Stencel C Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092 [TBL] [Abstract][Full Text] [Related]
16. Recommended system for surveillance and reporting of problems with large-volume parenterals in hospitals. Am J Hosp Pharm; 1975 Dec; 32(12):1251-3. PubMed ID: 1211398 [TBL] [Abstract][Full Text] [Related]
17. Premixed intravenous admixtures: a positive development for hospital pharmacy. Lee HE Am J Hosp Pharm; 1983 Jun; 40(6):1043-4. PubMed ID: 6869393 [TBL] [Abstract][Full Text] [Related]
18. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder. Foy JM; Earls MF Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972 [TBL] [Abstract][Full Text] [Related]
19. Cumulative sum control charts for admixture quality control. Sanford RL Am J Hosp Pharm; 1980 May; 37(5):655-9. PubMed ID: 7386472 [TBL] [Abstract][Full Text] [Related]